Human IgG antibody responses to severe acute respiratory syndrome coronavirus 2 viral antigens receptor-binding domain, spike, and nucleocapsid, in vaccinated adults from Merida, Mexico

Several vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been approved for controlling the coronavirus disease 2019 (COVID-19) pandemic worldwide. Antibody response is essential to understand the immune response to different viral targets after vaccination with diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Puerta-Guardo, Henry, Parra-Cardeña, Manuel, Peña-Miranda, Fernando, Flores-Quintal, Felipe, Granja-Pérez, Pilar, Villanueva-Jorge, Salha, González-Losa, Refugio, Conde-Ferraez, Laura, Gómez-Carballo, Jesus, Vazquez-Prokopec, Gonzalo, Earnest, James T., Manrique-Saide, Pablo, Ayora-Talavera, Guadalupe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354829/
https://www.ncbi.nlm.nih.gov/pubmed/35935758
http://dx.doi.org/10.3389/fmed.2022.916241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354829/
https://www.ncbi.nlm.nih.gov/pubmed/35935758
http://dx.doi.org/10.3389/fmed.2022.916241

Ejemplares similares